Skip to main content

YY1AP1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512), expandable thumbnail
  • Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (AB265512), expandable thumbnail

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2

Alternative names

Recommended products

YY1AP1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2.

Key facts

Cell type
HeLa
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2
Disease
Adenocarcinoma
Concentration
Loading...

Properties

Gene name
YY1AP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HeLa cell line (Human wild-type HeLa cell line ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

YY1AP1 also known as Yin Yang 1-Associated Protein 1 has a molecular weight of approximately 75 kDa. It mainly interacts with the YY1 transcription factor modulating transcriptional activity. Researchers find YY1AP1 expressed in various tissues with higher levels noted in the heart brain and liver. The protein localizes itself in both the nucleus and cytoplasm.

Biological function summary

YY1AP1 affects gene regulation and chromatin remodeling. It forms part of a transcriptional complex that includes YY1 and other cofactors. This complex impacts processes like cell proliferation and differentiation through manipulating transcription. YY1AP1 holds a strong role in influencing cellular homeostasis affecting development and cellular response to stress.

Pathways

YY1AP1 plays a role in pathways involving transcriptional regulation and chromatin dynamics. It participates in the Wnt signaling pathway and the p53 pathway. Within these pathways YY1AP1 associates with proteins like β-catenin and Mdm2 aiding in regulating cell cycle and apoptosis. The interactions show YY1AP1's importance in signal transduction and transcriptional response mechanisms.

Associated diseases and disorders

YY1AP1 connects to cancer and congenital heart disease. In cancer its interaction with YY1 and other transcription factors suggests a role in tumorigenesis where it affects cell cycle regulation and apoptosis. In congenital heart disease altered expression patterns of YY1AP1 or disruption of its interaction with key proteins like GATA4 could contribute to developmental defects. Understanding YY1AP1's involvement in these conditions might offer insight into therapeutic targets and mechanisms.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (ab265512), expandable thumbnail

    Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (ab265512)

    Allele-2: 1 bp insertion in exon 2.

  • Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (ab265512), expandable thumbnail

    Sanger Sequencing - Human YY1AP1 knockout HeLa cell line (ab265512)

    Allele-1: 2 bp deletion in exon 2.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com